These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7020585)

  • 21. Domestication of chemistry by design of safer chemicals: structure-activity relationships.
    Ariëns EJ
    Drug Metab Rev; 1984; 15(3):425-504. PubMed ID: 6386409
    [No Abstract]   [Full Text] [Related]  

  • 22. [Systematic presentation of rational research on new drugs].
    Ariëns EJ
    Farmaco Sci; 1968 Jan; 23(1):52-94. PubMed ID: 4892131
    [No Abstract]   [Full Text] [Related]  

  • 23. Mass spectrometry.
    Burlingame AL; Baillie TA; Derrick PJ
    Anal Chem; 1986 Apr; 58(5):165R-211R. PubMed ID: 3521386
    [No Abstract]   [Full Text] [Related]  

  • 24. Liposomes as drug carriers.
    Fendler JH; Romero A
    Life Sci; 1977 Apr; 20(7):1109-20. PubMed ID: 403379
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of adipose tissue in the distribution and storage of drugs.
    Bickel MH
    Prog Drug Res; 1984; 28():273-303. PubMed ID: 6435172
    [No Abstract]   [Full Text] [Related]  

  • 26. Forces involved ithe conformational stability of nucleic acids.
    Maurizot JC; Brahms J; Eckstein F
    Nature; 1969 May; 222(5193):559-61. PubMed ID: 5781656
    [No Abstract]   [Full Text] [Related]  

  • 27. Polyelectrolyte theory of charged-ligand binding to nucleic acids.
    Guéron M; Weisbuch G
    Biochimie; 1981; 63(11-12):821-5. PubMed ID: 7332745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A theoretical analysis of specificity of nucleic acid interactions with oligonucleotides and peptide nucleic acids (PNAs).
    Lomakin A; Frank-Kamenetskii MD
    J Mol Biol; 1998 Feb; 276(1):57-70. PubMed ID: 9514718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topography of nucleic acid helices in solutions. II. Structure of the double-stranded rA-rU, rI-rC, acid rA, and the triple-stranded rA-rU2 and rA-rI2 helices.
    Gabbay EJ
    Biopolymers; 1967; 5(8):727-47. PubMed ID: 6065974
    [No Abstract]   [Full Text] [Related]  

  • 30. Parabolic structure-activity relationships: a simple pharmacokinetic model.
    Aarons L; Bell D; Waigh R; Ye Q
    J Pharm Pharmacol; 1982 Nov; 34(11):746-9. PubMed ID: 6129312
    [No Abstract]   [Full Text] [Related]  

  • 31. Characteristics of drugs that penetrate the preimplantation blastocyst.
    Thithapandha A
    Biochem Pharmacol; 1980 Jun; 29(12):1663-8. PubMed ID: 7406895
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis of model compounds for the interaction between modified nucleic acid bases.
    Higashii T; Sakata Y; Misumi S
    Nucleic Acids Symp Ser; 1983; (12):173-6. PubMed ID: 6664856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chiral epoxides, their enantioselective reactivity towards nucleic acids, and a first outline of a quantum chemical structure-reactivity calculation.
    Peter H; Marczynski B; Wistuba D; Szentpály LV; Csanády G; Bolt HM
    Adv Exp Med Biol; 1991; 283():793-9. PubMed ID: 2069058
    [No Abstract]   [Full Text] [Related]  

  • 34. The development of a unified physico-chemical research line for studying the relationship between the resorption rates and the physico-chemical properties of drugs.
    Past T; Tapsonyi S; Jávor T
    Pol J Pharmacol Pharm; 1984; 36(4):401-6. PubMed ID: 6527971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computer graphics in the study of drug-nucleic acid interactions.
    Neidle S
    Biochem Soc Trans; 1984 Dec; 12(6):1008-11. PubMed ID: 6530027
    [No Abstract]   [Full Text] [Related]  

  • 36. Selectivity of alkylation and aralkylation of nucleic acid components.
    Dipple A; Moschel RC; Hudgins WR
    Drug Metab Rev; 1982; 13(2):249-68. PubMed ID: 6178574
    [No Abstract]   [Full Text] [Related]  

  • 37. Thermodynamic factors in the synthesis of two-stranded nucleic acids.
    Peller L
    Proc Natl Acad Sci U S A; 1966 May; 55(5):1025-31. PubMed ID: 4289200
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reactive oligonucleotide derivatives as potential antiviral preparations].
    Knorre DG; Vlasov VV
    Vopr Virusol; 1985; 30(5):524-9. PubMed ID: 2416132
    [No Abstract]   [Full Text] [Related]  

  • 39. Trends in searching for antitumor compounds.
    Preobrazhenskaya MN
    Natl Cancer Inst Monogr; 1977 Mar; (45):195-205. PubMed ID: 337151
    [No Abstract]   [Full Text] [Related]  

  • 40. Rate constants of absorption versus physico-chemical parameters.
    Past T; Tapsonyi Z; Nagy L; Jávor T
    Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):413-6. PubMed ID: 29840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.